rs6007897

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_001378328.1(CELSR1):​c.6802A>G​(p.Thr2268Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.174 in 1,613,128 control chromosomes in the GnomAD database, including 32,578 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.27 ( 8376 hom., cov: 32)
Exomes 𝑓: 0.16 ( 24202 hom. )

Consequence

CELSR1
NM_001378328.1 missense

Scores

18

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 0.117

Publications

42 publications found
Variant links:
Genes affected
CELSR1 (HGNC:1850): (cadherin EGF LAG seven-pass G-type receptor 1) The protein encoded by this gene is a member of the flamingo subfamily, part of the cadherin superfamily. The flamingo subfamily consists of nonclassic-type cadherins; a subpopulation that does not interact with catenins. The flamingo cadherins are located at the plasma membrane and have nine cadherin domains, seven epidermal growth factor-like repeats and two laminin A G-type repeats in their ectodomain. They also have seven transmembrane domains, a characteristic unique to this subfamily. It is postulated that these proteins are receptors involved in contact-mediated communication, with cadherin domains acting as homophilic binding regions and the EGF-like domains involved in cell adhesion and receptor-ligand interactions. This particular member is a developmentally regulated, neural-specific gene which plays an unspecified role in early embryogenesis. [provided by RefSeq, Jul 2008]
CELSR1 Gene-Disease associations (from GenCC):
  • lymphatic malformation 9
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • neural tube defects, susceptibility to
    Inheritance: AD Classification: MODERATE, LIMITED Submitted by: Illumina, Labcorp Genetics (formerly Invitae)
  • epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hydrops fetalis
    Inheritance: AD Classification: LIMITED Submitted by: G2P
  • genetic developmental and epileptic encephalopathy
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.0373151E-5).
BP6
Variant 22-46384624-T-C is Benign according to our data. Variant chr22-46384624-T-C is described in ClinVar as Benign. ClinVar VariationId is 3055407.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.576 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CELSR1NM_001378328.1 linkc.6802A>G p.Thr2268Ala missense_variant Exon 20 of 35 ENST00000674500.2 NP_001365257.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CELSR1ENST00000674500.2 linkc.6802A>G p.Thr2268Ala missense_variant Exon 20 of 35 NM_001378328.1 ENSP00000501367.2 A0A6I8PRU0

Frequencies

GnomAD3 genomes
AF:
0.267
AC:
40599
AN:
151946
Hom.:
8345
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.582
Gnomad AMI
AF:
0.194
Gnomad AMR
AF:
0.152
Gnomad ASJ
AF:
0.172
Gnomad EAS
AF:
0.0154
Gnomad SAS
AF:
0.0896
Gnomad FIN
AF:
0.111
Gnomad MID
AF:
0.190
Gnomad NFE
AF:
0.166
Gnomad OTH
AF:
0.221
GnomAD2 exomes
AF:
0.157
AC:
39241
AN:
250544
AF XY:
0.149
show subpopulations
Gnomad AFR exome
AF:
0.592
Gnomad AMR exome
AF:
0.0938
Gnomad ASJ exome
AF:
0.167
Gnomad EAS exome
AF:
0.0140
Gnomad FIN exome
AF:
0.110
Gnomad NFE exome
AF:
0.160
Gnomad OTH exome
AF:
0.154
GnomAD4 exome
AF:
0.164
AC:
239577
AN:
1461064
Hom.:
24202
Cov.:
32
AF XY:
0.161
AC XY:
116799
AN XY:
726818
show subpopulations
African (AFR)
AF:
0.595
AC:
19888
AN:
33444
American (AMR)
AF:
0.101
AC:
4524
AN:
44612
Ashkenazi Jewish (ASJ)
AF:
0.171
AC:
4474
AN:
26124
East Asian (EAS)
AF:
0.0153
AC:
608
AN:
39684
South Asian (SAS)
AF:
0.100
AC:
8622
AN:
86096
European-Finnish (FIN)
AF:
0.113
AC:
6011
AN:
53376
Middle Eastern (MID)
AF:
0.152
AC:
877
AN:
5760
European-Non Finnish (NFE)
AF:
0.166
AC:
184315
AN:
1111602
Other (OTH)
AF:
0.170
AC:
10258
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
9309
18619
27928
37238
46547
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6594
13188
19782
26376
32970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.267
AC:
40674
AN:
152064
Hom.:
8376
Cov.:
32
AF XY:
0.259
AC XY:
19242
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.582
AC:
24127
AN:
41424
American (AMR)
AF:
0.152
AC:
2316
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.172
AC:
597
AN:
3464
East Asian (EAS)
AF:
0.0155
AC:
80
AN:
5178
South Asian (SAS)
AF:
0.0882
AC:
425
AN:
4816
European-Finnish (FIN)
AF:
0.111
AC:
1178
AN:
10594
Middle Eastern (MID)
AF:
0.187
AC:
55
AN:
294
European-Non Finnish (NFE)
AF:
0.166
AC:
11258
AN:
67998
Other (OTH)
AF:
0.218
AC:
461
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1232
2464
3695
4927
6159
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
362
724
1086
1448
1810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.186
Hom.:
13825
Bravo
AF:
0.284
TwinsUK
AF:
0.161
AC:
598
ALSPAC
AF:
0.169
AC:
650
ESP6500AA
AF:
0.578
AC:
2548
ESP6500EA
AF:
0.154
AC:
1325
ExAC
AF:
0.166
AC:
20100
Asia WGS
AF:
0.0870
AC:
305
AN:
3478
EpiCase
AF:
0.167
EpiControl
AF:
0.166

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

CELSR1-related disorder Benign:1
Aug 02, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.051
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
1.1
DANN
Benign
0.21
DEOGEN2
Benign
0.044
T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.0079
N
LIST_S2
Benign
0.066
T
MetaRNN
Benign
0.000010
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-0.20
N
PhyloP100
0.12
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-0.18
N
REVEL
Benign
0.038
Sift
Benign
0.79
T
Sift4G
Benign
0.75
T
Polyphen
0.0030
B
Vest4
0.016
MPC
0.17
ClinPred
0.0012
T
GERP RS
0.59
Varity_R
0.025
gMVP
0.29
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6007897; hg19: chr22-46780521; COSMIC: COSV53089133; API